Ultragenyx Pharmaceutical annual gross margin
2017
2018
2022
2023
2024
2025
Ultragenyx Pharmaceutical Gross Margin Growth & History (RARE)
Ultragenyx Pharmaceutical's gross margin was 83.80% for fiscal 2025.
View full Ultragenyx Pharmaceutical company overviewUltragenyx Pharmaceutical annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 83.80% | −2.45 pp |
| 2024 | 2024-12-31 | 86.25% | −3.38 pp |
| 2023 | 2023-12-31 | 89.63% | −2.57 pp |
| 2022 | 2022-12-31 | 92.21% | — |
| 2018 | 2018-12-31 | 97.77% | −2.19 pp |
| 2017 | 2017-12-31 | 99.96% | — |
Ultragenyx Pharmaceutical quarterly gross margin
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 84.11% | −2.12 pp |
| Q1 2026 | 2026-03-31 | 77.94% | — |
| Q4 2025 | 2025-12-31 | 85.93% | — |
| Q3 2025 | 2025-09-30 | 82.50% | — |
| Q2 2025 | 2025-06-30 | 86.23% | — |
| Q2 2019 | 2019-06-30 | 96.83% | −2.07 pp |
| Q1 2019 | 2019-03-31 | 97.51% | −0.38 pp |
| Q4 2018 | 2018-12-31 | 96.88% | — |
| Q3 2018 | 2018-09-30 | 97.68% | — |
| Q2 2018 | 2018-06-30 | 98.90% | — |
| Q1 2018 | 2018-03-31 | 97.89% | — |
Ultragenyx Pharmaceutical gross margin trends
Between the periods ended 2017-12-31 and 2025-12-31, Ultragenyx Pharmaceutical's gross margin decreased from 99.96% to 83.80%, a change of −16.16 percentage points. The latest reported quarter, Q2 2026, shows 84.11%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ultragenyx Pharmaceutical source filings ↗